Presentation TCT 2015 The PIONEER Trial (Rivaroxaban in Patients With ACS and Atrial Fibrillation): Design, Rationale, and Status Presenter: Roxana Mehran October 14, 2015 REGISTER for free or LOG IN to view this content Presentation TCT 2015 Up Next Presentation TCT 2015 CE-Approved or EU Studies: JenaValve Technology Review and Clinical Update (JUPITER Trials) Presenter: Hendrik Treede October 14, 2015 More slides + Presentation TCT 2015 Acroredis, Iris Fit, and CARAG ASD Occluder Presenter: Horst Sievert October 14, 2015 Presentation TCT 2015 Overview of Stroke: Etiologies, Demographics, Syndromes, and Outcomes by the Rankin Scale Presenter: Alex Abou-Chebl October 14, 2015 We Recommend
Presentation TCT 2015 CE-Approved or EU Studies: JenaValve Technology Review and Clinical Update (JUPITER Trials) Presenter: Hendrik Treede October 14, 2015
Presentation TCT 2015 Acroredis, Iris Fit, and CARAG ASD Occluder Presenter: Horst Sievert October 14, 2015
Presentation TCT 2015 Overview of Stroke: Etiologies, Demographics, Syndromes, and Outcomes by the Rankin Scale Presenter: Alex Abou-Chebl October 14, 2015